Onderzoeker
Eric Derom
- Disciplines:Endocrinologie en metabole ziekten, Pediatrie en neonatologie, Verpleegkunde
Affiliaties
- Vakgroep Inwendige ziekten en Pediatrie (Departement)
Lid
Vanaf1 okt 2018 → Heden - Vakgroep Inwendige ziekten (Departement)
Lid
Vanaf1 feb 1994 → 30 sep 2018
Projecten
1 - 1 of 1
- ClinicalTrials.COV : follow up van patienten die meedoen aan interventionele klinische studies naar het gebruik van immunomodulatoren bij ernstige COVID-19 infectieVanaf15 apr 2020 → 14 jan 2021Financiering: BOF - projecten
Publicaties
21 - 30 van 50
- Changes in heart rate variability following deep breathing, tilting and valsalva maneuver techniques among subjects with chronic obstructive pulmonary disease(2017)
Auteurs: Jibril Mohammed, Eric Derom, Jessica Van Oosterwijck, Bihiyga Salhi, Hellen Da Silva Van den Bosch, Patrick Calders
Aantal pagina's: 1 - Symphonic music in occupied Belgium, 1940-1944 : the role of 'German-Friendly' music societies(2016)
Auteurs: Eric Derom
Pagina's: 109 - 125 - The lung function profile of once-daily tiotropium and olodaterol via Respimat® is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler® (ENERGITO® study)(2016)
Auteurs: Kai-Michael Beeh, Eric Derom, José Echave-Sustaeta, Lars Grönke, Alan Hamilton, Dongmei Zhai, Leif Bjermer
Pagina's: 193 - 205 - Efficacy of tiotropium-olodaterol fixed-dose combination in COPD(2016)
Auteurs: Eric Derom, Guy Brusselle, Guy Joos
Pagina's: 3163 - 3177 - Once-daily tiotropium and olodaterol fixed-dose combination via the respimat improves outcomes vs mono-components in COPD in two 1-year studies(2015)Volume: 20
Auteurs: M Chia, J Reid, R Buhl, Eric Derom, G Ferguson, F Maltais, E Pizzichini, H Watz, L Grönke, A Hamilton, et al.
Pagina's: 77 - 77 - Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4)(2015)
Auteurs: Roland Buhl, François Maltais, Roger Abrahams, Leif Bjermer, Eric Derom, Gary Ferguson, Matjaz Flezar, Jacques Hébert, Lorcan McGarvey, Emilio Pizzichini, et al.
Pagina's: 969 - 979 - Safety of once-daily tiotropium and olodaterol fixed-dose combination via the respimat in chronic obstructive pulmonary disease in two 1-year studies(2015)Volume: 20
Auteurs: M Chia, J Reid, R Buhl, R Abrahams, L Bjermer, Eric Derom, M Flezar, J Hébert, A Veale, L Grönke, et al.
Pagina's: 77 - 77 - The 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary disease(2015)
Auteurs: Kai-Michael Beeh, Jan Westerman, Anne-Marie Kirsten, Jacques Hébert, Lars Grönke, Alan Hamilton, Kay Tetzlaff, Eric Derom
Pagina's: 53 - 59 - New developments in inhaler devices within pharmaceutical companies: a systematic review of the impact on clinical outcomes and patient preferences(2015)
Auteurs: Vincent Ninane, Jan Vandevoorde, Didier Cataldo, Eric Derom, Giuseppe Liistro, Evert Munghen, Rudi Peché, Marc Schlesser, Geert Verleden, Walter Vincken
Pagina's: 1430 - 1438 - Once-daily tiotropium and olodaterol fixed-dose combination via the Respimat® improves outcomes versus mono-components in COPD in two 1-year studies(2014)Volume: 69
Auteurs: R Buhl, Eric Derom, G Ferguson, E Pizzichini, J Reid, H Watz, L Groenke, A Hamilton, K Tetzlaff, L Korducki, et al.
Pagina's: A188 - A189